NASDAQ$ICUI
ICU Medical Inc. · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
ICU Medical's second quarter results were consistent with expectations, showing growth in most product families except Vascular Access and IV Solutions.
ICU Medical reported second quarter revenue of $549.3 million, a decrease compared to $561.0 million in the same period last year. The company's GAAP gross profit increased to $192.3 million from $167.6 million, with a gross margin of 35% compared to 30% last year. GAAP net loss was $(9.9) million, or $(0.41) per diluted share, while adjusted diluted earnings per share was $1.88. Adjusted EBITDA was $98.1 million, compared to $84.7 million in the same quarter of the previous year.
- Second quarter revenue reached $549.3 million.
- GAAP gross profit increased to $192.3 million with a gross margin of 35%.
- GAAP net loss was $(9.9) million, or $(0.41) per diluted share.
- Adjusted diluted earnings per share was $1.88.
Headline financials
Revenue & EPS history
ICU Medical · Revenue · Quarterly
$549M
Revenue by segment
ICU Medical · $390M total across 2 segments · Q2 2023
- Consumables$237M+64.0%60.7%
- Infusion Systems$153M+75.5%39.3%
Forward guidance
ICU Medical narrowed the estimates of the range of its full year 2023 guidance of adjusted EBITDA from a range of $375 million to $425 million to a range of $375 million to $405 million and adjusted diluted earnings per share from a range of $5.75 to $7.25 to a range of $6.00 to $6.85.
Tailwinds
- Adjusted EBITDA is expected to be between $375 million and $405 million.
- Adjusted diluted earnings per share are projected to be between $6.00 and $6.85.
Headwinds
- GAAP net loss is estimated to be in the range of $(59) million to $(38) million.
- GAAP diluted loss per share is estimated to be in the range of $(2.42) to $(1.57).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+0.3%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.3%
Avg return
30 days after
52%
38 / 73 earnings
Positive
+22.4%
Q2 2024
Best reaction
-33.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.8% | -0.8% | +10.7% | |
| Q4 2025 | +4.8% | +3.6% | -16.3% | |
| Q3 2025 | +8.2% | +7.3% | +9.9% | |
| Q1 2025 | -3.3% | -4.9% | -6.9% | |
| Q4 2024 | -2.3% | -4.1% | -6.4% | |
| Q3 2024 | -1.9% | -5.8% | -7.1% | |
| Q2 2024 | +22.4% | +19.7% | +31.2% | |
| Q1 2024 | -0.1% | +6.3% | +7.6% | |
| Q4 2023 | +6.5% | -0.2% | +1.6% | |
| Q3 2023 | -17.8% | -20.2% | -15.9% | |
| Q2 2023 | -15.2% | -15.6% | -16.8% | |
| Q1 2023 | +13.3% | +8.7% | +3.9% | |
| Q4 2022 | -3.6% | -4.2% | -7.3% | |
| Q3 2022 | +6.7% | +21.4% | +11.8% | |
| Q2 2022 | -7.4% | -4.7% | -8.0% | |
| Q1 2022 | -10.4% | -15.0% | -14.9% | |
| Q4 2021 | +5.8% | +9.0% | +4.3% | |
| Q3 2021 | +2.1% | +2.7% | -6.4% | |
| Q2 2021 | +0.7% | +1.2% | +6.1% | |
| Q1 2021 | -5.0% | -6.5% | -2.1% | |
| Q4 2020 | -5.5% | -6.8% | -4.4% | |
| Q3 2020 | +0.6% | +4.8% | +5.6% | |
| Q2 2020 | +8.8% | +5.0% | +9.8% | |
| Q1 2020 | -8.8% | -13.7% | -8.0% | |
| Q4 2019 | -4.2% | -4.8% | -8.2% | |
| Q3 2019 | +6.9% | +4.3% | +6.8% | |
| Q2 2019 | -33.3% | -31.2% | -36.6% | |
| Q1 2019 | -2.7% | -3.3% | -2.2% | |
| Q4 2018 | +2.5% | -4.9% | -2.8% | |
| Q3 2018 | -10.6% | -14.8% | -10.6% | |
| Q2 2018 | +2.2% | +2.4% | +3.7% | |
| Q1 2018 | +1.4% | +4.3% | +12.4% | |
| Q4 2017 | +4.6% | +7.5% | +9.1% | |
| Q3 2017 | +8.6% | +10.1% | +11.7% | |
| Q2 2017 | -2.9% | -2.4% | +3.4% | |
| Q1 2017 | -0.2% | -0.1% | +6.2% | |
| Q4 2016 | +0.7% | -1.0% | +1.5% | |
| Q3 2016 | -0.4% | -0.9% | +2.5% | |
| Q2 2016 | +7.5% | +6.1% | +8.6% | |
| Q1 2016 | -1.0% | — | — | |
| Q4 2015 | -8.7% | — | — | |
| Q3 2015 | +5.8% | — | — | |
| Q2 2015 | +19.9% | — | — | |
| Q1 2015 | +7.3% | — | — | |
| Q4 2014 | +2.2% | — | — | |
| Q3 2014 | +13.6% | — | — | |
| Q2 2014 | +10.5% | — | — | |
| Q1 2014 | +3.3% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | +3.0% | — | — | |
| Q2 2013 | -6.7% | — | — | |
| Q1 2013 | +1.3% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | -0.2% | — | — | |
| Q1 2012 | +0.8% | — | — | |
| Q4 2011 | +1.9% | — | — | |
| Q3 2011 | +0.2% | — | — | |
| Q2 2011 | -3.9% | — | — | |
| Q1 2011 | +2.2% | — | — | |
| Q4 2010 | +0.1% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +3.4% | — | — | |
| Q1 2010 | -1.0% | — | — | |
| Q4 2007 | -1.0% | — | — | |
| Q4 2009 | -1.0% | — | — | |
| Q3 2009 | -0.8% | — | — | |
| Q3 2008 | -0.8% | — | — | |
| Q2 2009 | -0.6% | — | — | |
| Q2 2008 | -3.9% | — | — | |
| Q1 2009 | -3.9% | — | — | |
| Q4 2008 | -3.9% | — | — | |
| Q1 2008 | -3.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro